Neuroendocrine Tumors

These are rare tumors that start in cells that make hormones. They can grow in different parts of the body, like the pancreas, lungs, or stomach. They often make too much hormone, which can cause problems like high blood sugar or high blood pressure.

Condition

What people with Neuroendocrine Tumors report

Every report comes from a Lived member, sent anonymously.

Have you tried Octreotide for Neuroendocrine Tumors?

NameHow it went

About Neuroendocrine Tumors

What It Is

Neuroendocrine tumors (NETs) are uncommon growths that start in neuroendocrine cells, which behave partly like nerve cells and partly like hormone-making gland cells. These cells are scattered through the body, so NETs can form in many places, but most begin in the digestive tract (especially the small intestine, appendix and rectum), the lungs or the pancreas. NETs of the gut and lungs used to be called carcinoid tumors, and pancreatic NETs are also known as islet cell tumors. Pancreatic NETs are a different disease from the more common type of pancreatic cancer. Most NETs grow slowly, and many cause no symptoms for years. Some are found by chance during a scan, colonoscopy or surgery for something else. Others cause symptoms as they grow, such as abdominal pain, changes in bowel habits, cough or unexplained weight loss. NETs are also sorted by whether they release hormones. Nonfunctional tumors do not, so they are often found later. Functional tumors release hormones that cause their own set of symptoms. A gut NET that has spread to the liver can cause carcinoid syndrome, with episodes of flushing (sudden warmth and redness of the face and neck), diarrhea and sometimes wheezing. Some pancreatic NETs make specific hormones: an insulinoma releases insulin and causes episodes of low blood sugar, and a gastrinoma drives excess stomach acid, leading to ulcers and diarrhea.

Causes & Risk Factors

NETs develop when neuroendocrine cells start dividing out of control, and in most people the reason is unknown. Most occur in people with no inherited cause, and they are most often diagnosed between the ages of 50 and 60. A small share are linked to inherited syndromes that raise the risk of several kinds of tumors. The best known is multiple endocrine neoplasia type 1 (MEN1); von Hippel-Lindau syndrome, neurofibromatosis type 1 and tuberous sclerosis complex are others. For stomach NETs, long-term conditions that reduce stomach acid, such as atrophic gastritis and pernicious anemia, increase risk. For pancreatic NETs, smoking, type 2 diabetes, chronic pancreatitis and a family history of cancer are associated with higher risk. These associations do not mean any single factor caused a particular tumor.

How It's Diagnosed

Because early symptoms are vague or absent, it can take a long time to reach a diagnosis. The workup usually combines blood or urine tests, imaging and a tissue sample. Blood and urine tests look for substances that NETs release. Chromogranin A is a protein often raised in people with NETs, and a 24-hour urine collection for 5-HIAA (a breakdown product of serotonin) helps confirm carcinoid syndrome. When a hormone-producing pancreatic tumor is suspected, specific hormones such as insulin or gastrin are measured. These tests support the diagnosis but cannot make it alone, since other conditions and some medicines can also raise the results. CT or MRI scans show where a tumor is and whether it has spread. Many NETs carry receptors for the hormone somatostatin, so a special PET scan using a tracer that attaches to these receptors (such as gallium-68 dotatate) can find small tumors and spread that other scans miss. It also shows whether treatments that target those receptors are likely to work. Endoscopy, colonoscopy or an endoscopic ultrasound (a camera tube with an ultrasound probe) can view a tumor directly and take a sample. A biopsy confirms the diagnosis and sets the grade, which describes how abnormal the cells look and how quickly they are dividing. Well-differentiated tumors (most grade 1 and 2 tumors) look closer to normal cells and grow slowly. Poorly differentiated tumors grow quickly and are treated more like other aggressive cancers. Grade, together with where the tumor started and whether it has spread, guides almost every treatment decision. Genetic testing may be suggested for people diagnosed young, with more than one tumor, a hormone-producing pancreatic tumor or a family history.

Treatment Options

Treatment depends on where the tumor started, its grade, whether it releases hormones and whether it has spread. Many people are cared for by a team that includes surgeons, oncologists, endocrinologists and nuclear medicine specialists, ideally at a center that sees NETs regularly. Surgery is the main treatment, and removing a tumor that has not spread can cure it. Small tumors in the stomach, rectum or duodenum (the first part of the small intestine) can sometimes be removed through an endoscope, while others need part of the intestine, appendix, pancreas or lung removed. Some small, slow-growing pancreatic NETs that cause no problems may be watched with regular scans instead of removed right away. Even when a NET has spread, removing or destroying tumors in the liver can relieve hormone symptoms and is sometimes part of the plan. For tumors that cannot be fully removed, the goal is to control growth and symptoms for as long as possible. Somatostatin analogs, long-acting injections such as octreotide (Sandostatin) and lanreotide (Somatuline Depot), mimic a natural hormone that switches off hormone release. They reduce flushing and diarrhea and can slow tumor growth in well-differentiated tumors, usually given every four weeks. If a tumor grows despite these injections, other options include peptide receptor radionuclide therapy (PRRT), in which a radioactive drug attaches to the somatostatin receptors and delivers radiation directly to tumor cells. Lutetium Lu 177 dotatate (Lutathera) is approved for these receptor-positive tumors of the digestive tract and pancreas. It is given in a few infusions spaced weeks apart and requires monitoring of blood counts and kidney function. Targeted pills such as everolimus or sunitinib slow growth in some tumors, chemotherapy is used more often for pancreatic or faster-growing tumors, and procedures that block or deliver treatment through the liver's blood supply can shrink liver tumors. Clinical trials are a reasonable option at many stages.

What to Expect

Outlook varies more than for most cancers. A small tumor removed completely, such as one found in the appendix or rectum, may need little more than follow-up. A well-differentiated tumor that has spread is often a long-term condition: many people live for years, working and carrying on with daily life while treatment keeps the disease stable. Fast-growing, poorly differentiated tumors have a more serious outlook. Living with an advanced NET usually means regular injections, blood tests and scans every few months at first, with longer intervals if things stay stable. NETs can return years after surgery, so follow-up continues long term. Fatigue and diarrhea are common, from the tumor or its treatment, and a dietitian can help with eating and weight. People with carcinoid syndrome often notice that alcohol, large meals, spicy foods or stress bring on flushing, and keeping track can help. Over years, hormones from carcinoid syndrome can damage heart valves, so periodic heart checks with an echocardiogram (an ultrasound of the heart) are part of care. Before any surgery, procedure or anesthesia, people with carcinoid syndrome should make sure the team knows, because extra medicine may be given beforehand to prevent a sudden surge of hormones. Because NETs are rare, support groups and specialist centers can be especially helpful for finding information and others with the same diagnosis.

When to Seek Help

See a doctor about repeated flushing episodes, long-lasting diarrhea, unexplained weight loss, ongoing abdominal pain, a persistent cough or blood in the stool, especially when they do not settle with usual treatment. If you have a NET, contact your care team when flushing, diarrhea or wheezing appear or become more frequent, when symptoms change, or when treatment side effects are hard to manage. With a known insulinoma, eat or drink something with sugar at the first signs of low blood sugar, such as sweating, shakiness, hunger or confusion, and tell your care team about the episodes. Call 911 for anyone who passes out, has a seizure or is too confused to swallow safely. Go to the emergency room right away for sudden severe shortness of breath, particularly with new swelling of the ankles and legs, which can signal heart trouble linked to carcinoid syndrome.

Questions to Ask Your Doctor

  1. 1.Where did my tumor start, what grade is it, and does it release hormones?
  2. 2.Can the tumor be removed completely, and if not, what is the goal of treatment?
  3. 3.Does a somatostatin receptor PET scan show that I could benefit from somatostatin analogs or PRRT?
  4. 4.How often will I need scans and blood tests, and what changes would make us switch treatment?
  5. 5.Should I have genetic testing, and do my family members need to be checked?

Last reviewed • Oct 2026

Educational content, not medical advice.